Simmons Hanly Conroy


Recent News About Simmons Hanly Conroy View More

Judge orders new trial, tosses $140M verdict vs AbbVie over Androgel testosterone drug

By Jonathan Bilyk | Jul 5, 2018

A federal judge has knocked down a $140 million verdict against pharmaceutical maker AbbVie, ordering a new trial over a man’s claims AbbVie’s Androgel testosterone replacement therapy drug caused him to suffer a heart attack.

Verdict much lower, but AbbVie wants $3.2M award tossed in second testosterone class action test trial

By Dan Churney | Apr 30, 2018

North Chicago-based drugmaker AbbVie is resisting what it is calling a jury's “confused and inconsistent” $3.2 million verdict, after the company lost a second trial in Chicago federal court – one in which it was ordered to pay $147 million less than the first trial – over a man’s claims AbbVie allegedly failed to warn its product AndroGel could bring on a heart attack.

Report: Asbestos litigation declines nationwide, slightly in Cook Co., still pervasive in three IL counties

By Jonathan Bilyk and Ann Maher | Mar 23, 2018

As the number of new asbestos lawsuits declined nationally, activity in Illinois’ three hotbeds for asbestos litigation showed few signs of ebbing in 2017, even though the distribution of filing activity has shifted slightly.

The Record Network